In diabetic nephropathy, the expression of KIM1 is high, but (−)-epigallocatechin gallate intake has been shown to ameliorate hyperglycemia, hyperlipidemia, AGEs, renal pathological changes, renal dysfunction, and abnormal KIM1 protein expression. This evidence concerns the gene HAVCR1 and Hyperglycemia.